EP2967837A1 - Medizinische seidenvorrichtung zur verwendung in der brustvergrösserung und brustrekonstruktion - Google Patents
Medizinische seidenvorrichtung zur verwendung in der brustvergrösserung und brustrekonstruktionInfo
- Publication number
- EP2967837A1 EP2967837A1 EP13826905.5A EP13826905A EP2967837A1 EP 2967837 A1 EP2967837 A1 EP 2967837A1 EP 13826905 A EP13826905 A EP 13826905A EP 2967837 A1 EP2967837 A1 EP 2967837A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- mesh
- breast
- fabric
- panel
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000000481 breast Anatomy 0.000 title claims abstract description 347
- 230000003416 augmentation Effects 0.000 title description 23
- 239000004744 fabric Substances 0.000 claims abstract description 238
- 238000001356 surgical procedure Methods 0.000 claims abstract description 40
- 239000007943 implant Substances 0.000 claims description 164
- 238000010276 construction Methods 0.000 claims description 22
- 238000003780 insertion Methods 0.000 claims description 13
- 230000037431 insertion Effects 0.000 claims description 13
- 238000007493 shaping process Methods 0.000 claims description 10
- 230000007704 transition Effects 0.000 claims description 6
- 230000000704 physical effect Effects 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 description 157
- 238000000034 method Methods 0.000 description 104
- 210000003491 skin Anatomy 0.000 description 50
- 238000009940 knitting Methods 0.000 description 41
- 210000003195 fascia Anatomy 0.000 description 37
- 239000000463 material Substances 0.000 description 35
- 239000011148 porous material Substances 0.000 description 30
- 238000013461 design Methods 0.000 description 29
- 235000004879 dioscorea Nutrition 0.000 description 27
- 210000004872 soft tissue Anatomy 0.000 description 27
- 239000000835 fiber Substances 0.000 description 24
- 230000008439 repair process Effects 0.000 description 24
- 210000004304 subcutaneous tissue Anatomy 0.000 description 20
- 210000002808 connective tissue Anatomy 0.000 description 18
- 210000003205 muscle Anatomy 0.000 description 18
- 230000008520 organization Effects 0.000 description 18
- -1 polypropylene Polymers 0.000 description 18
- 210000000779 thoracic wall Anatomy 0.000 description 18
- 239000004743 Polypropylene Substances 0.000 description 15
- 238000006073 displacement reaction Methods 0.000 description 15
- 229920001155 polypropylene Polymers 0.000 description 15
- 210000004883 areola Anatomy 0.000 description 14
- 238000005259 measurement Methods 0.000 description 14
- 108010022355 Fibroins Proteins 0.000 description 13
- 238000005520 cutting process Methods 0.000 description 12
- 230000007547 defect Effects 0.000 description 12
- 210000002976 pectoralis muscle Anatomy 0.000 description 12
- 230000008093 supporting effect Effects 0.000 description 12
- 238000002513 implantation Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000003387 muscular Effects 0.000 description 10
- 239000004753 textile Substances 0.000 description 10
- 230000017423 tissue regeneration Effects 0.000 description 10
- 108010023728 Alloderm Proteins 0.000 description 9
- 206010019909 Hernia Diseases 0.000 description 9
- 238000009986 fabric formation Methods 0.000 description 9
- 210000003041 ligament Anatomy 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 230000002500 effect on skin Effects 0.000 description 8
- 230000035882 stress Effects 0.000 description 8
- 238000007920 subcutaneous administration Methods 0.000 description 8
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 7
- 239000012984 antibiotic solution Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 230000000670 limiting effect Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000002775 capsule Substances 0.000 description 6
- 238000002316 cosmetic surgery Methods 0.000 description 6
- 235000012489 doughnuts Nutrition 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 210000000062 pectoralis major Anatomy 0.000 description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 6
- 239000004810 polytetrafluoroethylene Substances 0.000 description 6
- 230000003319 supportive effect Effects 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 241000446313 Lamella Species 0.000 description 5
- 206010062575 Muscle contracture Diseases 0.000 description 5
- 108010013296 Sericins Proteins 0.000 description 5
- 206010040102 Seroma Diseases 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 208000006111 contracture Diseases 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 210000004207 dermis Anatomy 0.000 description 5
- 238000005755 formation reaction Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 210000000513 rotator cuff Anatomy 0.000 description 5
- 238000007665 sagging Methods 0.000 description 5
- 231100000241 scar Toxicity 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 210000000115 thoracic cavity Anatomy 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 235000011475 lollipops Nutrition 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 229920004937 Dexon® Polymers 0.000 description 3
- 206010018852 Haematoma Diseases 0.000 description 3
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 3
- 108010027820 NeoForm Proteins 0.000 description 3
- 208000006735 Periostitis Diseases 0.000 description 3
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 239000004792 Prolene Substances 0.000 description 3
- 210000003815 abdominal wall Anatomy 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 229960004716 idoxuridine Drugs 0.000 description 3
- 210000005075 mammary gland Anatomy 0.000 description 3
- 210000003903 pelvic floor Anatomy 0.000 description 3
- 210000003460 periosteum Anatomy 0.000 description 3
- 239000004633 polyglycolic acid Substances 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 210000001562 sternum Anatomy 0.000 description 3
- 210000004003 subcutaneous fat Anatomy 0.000 description 3
- 238000009864 tensile test Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 238000012935 Averaging Methods 0.000 description 2
- 241001631457 Cannula Species 0.000 description 2
- 206010015995 Eyelid ptosis Diseases 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003601 intercostal effect Effects 0.000 description 2
- 238000007629 laparoscopic insertion Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 201000003004 ptosis Diseases 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- 208000021970 Abdominal wall defect Diseases 0.000 description 1
- 241001142920 Apantesis f-pallida Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 108091008102 DNA aptamers Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010051425 Enterocutaneous fistula Diseases 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 101710091977 Hydrophobin Proteins 0.000 description 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
- 208000008081 Intestinal Fistula Diseases 0.000 description 1
- 241001272720 Medialuna californiensis Species 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034268 Pelvic prolapse Diseases 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 108010025435 Permacol Proteins 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 108091008103 RNA aptamers Proteins 0.000 description 1
- 206010041101 Small intestinal obstruction Diseases 0.000 description 1
- 208000003220 Symmastia Diseases 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 210000001264 anterior cruciate ligament Anatomy 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002975 chemoattractant Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000003898 enterocutaneous fistula Effects 0.000 description 1
- 238000009661 fatigue test Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 102000034238 globular proteins Human genes 0.000 description 1
- 108091005896 globular proteins Proteins 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000009731 jinlong Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- JTIGKVIOEQASGT-UHFFFAOYSA-N proquazone Chemical compound N=1C(=O)N(C(C)C)C2=CC(C)=CC=C2C=1C1=CC=CC=C1 JTIGKVIOEQASGT-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001528 ptotic effect Effects 0.000 description 1
- 238000002278 reconstructive surgery Methods 0.000 description 1
- 238000012079 reconstructive surgical procedure Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses and implants
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/843,519 US20130304098A1 (en) | 2008-12-15 | 2013-03-15 | Silk medical device for use in breast augmentation and breast reconstruction |
| PCT/US2013/075053 WO2014149096A1 (en) | 2013-03-15 | 2013-12-13 | Silk medical device for use in breast augmentation and breast reconstruction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2967837A1 true EP2967837A1 (de) | 2016-01-20 |
Family
ID=50033765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP13826905.5A Withdrawn EP2967837A1 (de) | 2013-03-15 | 2013-12-13 | Medizinische seidenvorrichtung zur verwendung in der brustvergrösserung und brustrekonstruktion |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP2967837A1 (de) |
| KR (1) | KR20150131039A (de) |
| AU (1) | AU2013383409A1 (de) |
| BR (1) | BR112015021365A2 (de) |
| CA (1) | CA2900682A1 (de) |
| CL (1) | CL2015002371A1 (de) |
| WO (1) | WO2014149096A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10363127B2 (en) * | 2017-11-13 | 2019-07-30 | Surgical Innovation Associates, Inc. | Mesh pouch for medical implant and method for using same |
| SE1950556A1 (en) * | 2019-05-09 | 2020-11-10 | Novus Scientific Ab | Tubular mesh support device for a breast implant |
| WO2021063851A1 (en) * | 2019-10-03 | 2021-04-08 | Novus Scientific Ab | Mesh support device for a breast implant |
| WO2021063850A1 (en) * | 2019-10-03 | 2021-04-08 | Novus Scientific Ab | Mesh support device for a breast implant and a method for fixating a breast implant in a mesh support device |
| SE544808C2 (en) * | 2020-03-13 | 2022-11-22 | Novus Scientific Ab | Tubular mesh support device, for an implant, with different circumferential areas |
| US20210393388A1 (en) * | 2020-06-19 | 2021-12-23 | Davol Inc. | Implantable prosthesis |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB545153A (en) * | 1940-11-09 | 1942-05-13 | Towles Ltd | Improvements in seamless hosiery and the method of making same |
| GB723301A (en) * | 1948-05-31 | 1955-02-09 | Bernard Thornton Reymes Reymes | Improvements in knitting machines and their products and methods of producing knitted fabric |
| US5584884A (en) | 1995-07-27 | 1996-12-17 | Anthony S. Pignataro | Mammary prosthesis and method of surgically implanting same |
| US6085754A (en) * | 1998-07-13 | 2000-07-11 | Acorn Cardiovascular, Inc. | Cardiac disease treatment method |
| US20040176658A1 (en) * | 2003-03-03 | 2004-09-09 | Mcmurray Brian | Warp knit fabrics useful for medical articles and methods of making same |
| ATE487441T1 (de) | 2007-06-01 | 2010-11-15 | Allergan Inc | Gerät zur erzeugung des zugspannungsinduzierten wachstums von biologischem gewebe |
| US20120185041A1 (en) * | 2008-12-15 | 2012-07-19 | Allergan, Inc. | Silk medical device for use in breast augmentation and breast reconstruction |
| US9204953B2 (en) * | 2008-12-15 | 2015-12-08 | Allergan, Inc. | Biocompatible surgical scaffold with varying stretch |
| BRPI0922440A2 (pt) * | 2008-12-15 | 2018-10-23 | Allergan Inc | dispositivo protético e método de fabricação do mesmo . |
-
2013
- 2013-12-13 CA CA2900682A patent/CA2900682A1/en not_active Abandoned
- 2013-12-13 EP EP13826905.5A patent/EP2967837A1/de not_active Withdrawn
- 2013-12-13 AU AU2013383409A patent/AU2013383409A1/en not_active Abandoned
- 2013-12-13 BR BR112015021365A patent/BR112015021365A2/pt not_active IP Right Cessation
- 2013-12-13 WO PCT/US2013/075053 patent/WO2014149096A1/en active Application Filing
- 2013-12-13 KR KR1020157025057A patent/KR20150131039A/ko not_active Application Discontinuation
-
2015
- 2015-08-24 CL CL2015002371A patent/CL2015002371A1/es unknown
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2014149096A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015021365A2 (pt) | 2017-07-18 |
| AU2013383409A1 (en) | 2015-09-10 |
| CL2015002371A1 (es) | 2016-03-11 |
| CA2900682A1 (en) | 2014-09-25 |
| WO2014149096A1 (en) | 2014-09-25 |
| KR20150131039A (ko) | 2015-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20170258573A1 (en) | Silk medical device for use in breast augmentation and breast reconstruction | |
| US20120185041A1 (en) | Silk medical device for use in breast augmentation and breast reconstruction | |
| US20120004723A1 (en) | Prosthetic device and method of using in breast augmentation and/or breast reconstruction | |
| US20120022646A1 (en) | Prosthetic device and method of using in breast augmentation and/or breast reconstruction | |
| US9204953B2 (en) | Biocompatible surgical scaffold with varying stretch | |
| CA2858552C (en) | A prosthetic device and method of manufacturing the same | |
| US20140088700A1 (en) | Method for using a silk derived bioresorbable scaffold in breast reconstruction | |
| US9308070B2 (en) | Pliable silk medical device | |
| US20140277000A1 (en) | Implantable silk prosthetic device and uses thereof | |
| WO2014149096A1 (en) | Silk medical device for use in breast augmentation and breast reconstruction | |
| US10648109B2 (en) | Pliable silk medical device | |
| WO2016028797A1 (en) | Pliable silk medical device | |
| AU2012245669B2 (en) | A prosthetic device and method of manufacturing the same | |
| NZ617461B2 (en) | A prosthetic device and method of manufacturing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20150813 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20170406 |